Delivery Order SPE2DB25D3306-SPE2DB25FUBKT
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count packaging) under a firm fixed price contract valued at $2,466.80. This delivery order, which was not set-aside, is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction for pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin HCL 500 mg tablets (100-count) valued at $2,362.87 under a firm fixed price contract. The award was made on May 27, 2025, with an ultimate completion date of May 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ciprofloxacin HCL 250 mg tablets (100-count units) with a ceiling value of $1,069.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 30, 2025, for Ciprofloxacin HCL 500 mg tablets (100-count) with a ceiling value of $1,877.16. This firm fixed-price delivery order, with completion targeted for July 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and primary pharmaceutical distributor for this...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Ciprofloxacin HCl 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,822.55. This is a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100 count). This non-set-aside competitive award carries a ceiling value of $1,957.82 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin HCl 500 mg tablets (100 count) valued at $1,850.73 on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a relatively small-value pharmaceutical procurement typical of routine medical supply replenishment. The award was made to AmerisourceBergen's Corporate Office division, located in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100, with a ceiling value of $1,019.21. This is a firm fixed price, non-set-aside delivery order that will be completed by August 28, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100-count bottles) with a ceiling value of $1,564.30. This firm fixed-price delivery order, which is set to be completed by September 16, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a non-set-aside competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBKTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets (100 count) with a ceiling value of $2,834.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a wide range of pharmaceutical products and medical supplies to federal agencies, particularly supporting military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates extensive capability in delivering generic and brand-name medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery of this antibiotic medication supports the Department of Defense's medical supply chain requirements and reflects the company's established role as a critical vendor for federal pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/21/25 |